VITASORA HEALTH LIMITED - Announcements

3.70%

2.8¢

Market Cap $48.11M

Technology Scientific & Technical Instruments

Vitasora Health Limited, formerly Respiri Limited, is an Australia-based healthcare... Vitasora Health Limited, formerly Respiri Limited, is an Australia-based healthcare technology and services company that focuses on digital Connected Care in the United States healthcare market. The Company offers remote patient monitoring (RPM) and chronic care management (CCM) services. Its Care Management model enables healthcare organizations to extend care beyond their clinics, integrating multi-device remote monitoring, virtual clinical support, and artificial intelligence (AI)-powered decision-making.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

VHL	Voluntary Suspension	PRICE SENSITIVE	29/04/22	188KB	Share
VHL	Trading Halt	PRICE SENSITIVE	27/04/22	187.99KB	Share
VHL	Final Director's Interest Notice - TD		26/04/22	196.09KB	Share
VHL	Director Resignation - TD		19/04/22	127.22KB	Share
VHL	EAS Advisors LLC appointed to assist with US growth		29/03/22	174.07KB	Share
VHL	Broker Briefing - full presentation		29/03/22	207.1KB	Share
VHL	Tech/Biotech Webinar - presentation		24/03/22	1.07MB	Share
VHL	CEO to present at Tech/Biotech Investor Webinar		23/03/22	228.35KB	Share
VHL	RPM pilot program at Children's Hospital of Michigan	PRICE SENSITIVE	15/03/22	137.09KB	Share
VHL	Notification regarding unquoted securities - RSH		25/02/22	27.76KB	Share
VHL	Half Yearly Report and Accounts	PRICE SENSITIVE	21/02/22	1.53MB	Share
VHL	Investor webinar and Q&A to be held Feb 23rd		21/02/22	120.38KB	Share
VHL	Second RPM Agreement with Access TeleHealth	PRICE SENSITIVE	07/02/22	150.14KB	Share
VHL	Respiri secures a second order from mTeleHealth	PRICE SENSITIVE	04/02/22	146.68KB	Share
VHL	Proposed issue of securities - RSH		03/02/22	30.02KB	Share
VHL	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/01/22	312.71KB	Share
VHL	Respiri enters Distribution/Marketing Agreement in USA	PRICE SENSITIVE	23/12/21	148.6KB	Share
VHL	Respiri to present today at MST Financial Forum		25/11/21	140.23KB	Share
VHL	Respiri to present at NWR Virtual Healthcare Day		22/11/21	120.82KB	Share
VHL	Results of AGM		15/11/21	162.64KB	Share
VHL	AGM - Chairman's Address and CEO presentation		15/11/21	2.03MB	Share
VHL	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	26/10/21	302.49KB	Share
VHL	Notice of General Meeting		14/10/21	744.89KB	Share
VHL	Annual Report - Corporate Governance Statement		27/08/21	166.24KB	Share
VHL	Annual Report - App 4G		27/08/21	289.35KB	Share
VHL	Preliminary Final Report	PRICE SENSITIVE	27/08/21	4.45MB	Share
VHL	NWR Conference Presentation - amended		05/08/21	2.73MB	Share
VHL	NWR Conference Presentation		03/08/21	3.08MB	Share
VHL	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/07/21	310.91KB	Share
VHL	Respiri to present at NWR Virtual Investor Conference		29/07/21	120.47KB	Share
VHL	Top 20 shareholders and Distribution Schedule		21/07/21	254.51KB	Share
VHL	T/O Bid lapsed and Ceasing to be sub. shareholder for ADR		19/07/21	319.82KB	Share
VHL	Defeating Conditions Notice		08/07/21	292.2KB	Share
VHL	Clarification Announcement	PRICE SENSITIVE	05/07/21	389.56KB	Share
VHL	Response to ASX Query	PRICE SENSITIVE	02/07/21	487.94KB	Share
VHL	ADR: Despatch of Target's Statement		30/06/21	249.94KB	Share
VHL	ADR: Target's Statement	PRICE SENSITIVE	28/06/21	9.29MB	Share
VHL	Webinar presentation - Investor Update	PRICE SENSITIVE	23/06/21	3.05MB	Share
VHL	Pharmacy Network to Commence Sales of wheezo	PRICE SENSITIVE	23/06/21	121.69KB	Share
VHL	Change of Director's Interest Notice - MM		22/06/21	545.44KB	Share
VHL	Investor webinar & Q&A		22/06/21	120.45KB	Share
VHL	ADR: Letter to Shareholders re takeover offer	PRICE SENSITIVE	17/06/21	132.62KB	Share
VHL	Notice of Dispatch		15/06/21	2.03MB	Share
VHL	Trading Update	PRICE SENSITIVE	15/06/21	125.49KB	Share
VHL	wheezo Registered and Approved for Sale in the UK Market		11/06/21	124.56KB	Share
VHL	ADR: Adherium responds to Respiri announcement		07/06/21	126.28KB	Share
VHL	RPM CPT Reimbursement & response to statements made by ADR		03/06/21	152.86KB	Share
VHL	wheezo production update &Chief Commercial Offer appointment		31/05/21	374.65KB	Share
VHL	Replacement Bidders Statement	PRICE SENSITIVE	27/05/21	2.47MB	Share
VHL	1st Supplementary Bidder's Statement(marked up replacement	PRICE SENSITIVE	27/05/21	2.7MB	Share
VHL	Major Shareholder Update		27/05/21	944.58KB	Share
VHL	Notice under section 633(4) Corps Act 2001		10/05/21	75.41KB	Share
VHL	ADR: Adherium Directors' Statement re Takeover	PRICE SENSITIVE	10/05/21	138.41KB	Share
VHL	Proposed issue of Securities - RSH		30/04/21	25.12KB	Share
VHL	Notice of initial substantial holder for ADR		30/04/21	172.99KB	Share
VHL	ADR: Adherium response to Respiri announcement	PRICE SENSITIVE	30/04/21	169.84KB	Share
VHL	Bidder's Statement	PRICE SENSITIVE	29/04/21	2.02MB	Share
VHL	Appendix 4C - quarterly	PRICE SENSITIVE	29/04/21	306.97KB	Share
VHL	Respiri Partnership with TerryWhite Chemmart Group	PRICE SENSITIVE	28/04/21	120.61KB	Share
VHL	Respiratory Physician led programme launching in Australia		29/03/21	121.76KB	Share
VHL	Strategic Advisor Appointments and UK Update		25/03/21	139.27KB	Share
VHL	Investor Presentation	PRICE SENSITIVE	23/03/21	1.89MB	Share
VHL	US FDA Clearance received	PRICE SENSITIVE	23/03/21	160.2KB	Share
VHL	Webinar and Q&A to be held tomorrow morning		22/03/21	115.08KB	Share
VHL	Trading Halt	PRICE SENSITIVE	19/03/21	515.04KB	Share
VHL	Investor Presentation - NWR conference		19/03/21	2.33MB	Share
VHL	Appendix 2A - exercise of options		18/03/21	284.95KB	Share
VHL	Proposed issue of Securities - RSH		18/03/21	24.22KB	Share
VHL	Respiri to present at NWR Comm.s Virtual Investor Conference		15/03/21	115.14KB	Share
VHL	Half Year Accounts	PRICE SENSITIVE	19/02/21	462.38KB	Share
VHL	Pharmacy Catalyst Members In-Pharmacy Asthma Mgt Program		08/02/21	125.89KB	Share
VHL	Change of Director's Interest Notice - TD		02/02/21	237.06KB	Share
VHL	Change of Director's Interest Notice - MM		02/02/21	421.32KB	Share
VHL	Change of Director's Interest Notice - NS		02/02/21	630.88KB	Share
VHL	Appendix 4C - quarterly	PRICE SENSITIVE	27/01/21	330.59KB	Share
VHL	Appendix 2A - exercise of options		18/01/21	285.58KB	Share
VHL	SuperChem to Commence Sales of wheezo		14/01/21	103.52KB	Share
VHL	Appendix 3G		29/12/20	334.48KB	Share
VHL	Proposed issue of Securities - RSH		23/12/20	31.76KB	Share
VHL	Results of Annual General Meeting		16/12/20	163.11KB	Share
VHL	CEO's Update at AGM		16/12/20	1.46MB	Share
VHL	Change of Director's Interest Notice - MM		16/12/20	414.94KB	Share
VHL	Change of Director's Interest Notice - NS		16/12/20	637.22KB	Share
VHL	New Partnership with Pharmacy 4 Less Banner Group		16/12/20	121.06KB	Share
VHL	Company Update Post Commercial Launch	PRICE SENSITIVE	09/12/20	136.35KB	Share
VHL	Michael Clarke Ambassador & Carlton AFLW co-sponsor		04/12/20	121.95KB	Share
VHL	Appendix 2A		25/11/20	281.6KB	Share
VHL	Notice of Annual General Meeting		12/11/20	1.94MB	Share
VHL	Manufacturing update	PRICE SENSITIVE	04/11/20	141.03KB	Share
VHL	wheezo Launch Update		30/10/20	124.52KB	Share
VHL	Patent application filed - Next Generation wheezo algorithm		29/10/20	138.58KB	Share
VHL	Appendix 2A		28/10/20	286.11KB	Share
VHL	Amended - Change in substantial holding		23/10/20	1.46MB	Share
VHL	Change in substantial holding		23/10/20	1.44MB	Share
VHL	Appendix 4C - quarterly	PRICE SENSITIVE	22/10/20	332.42KB	Share
VHL	Cipla launches wheezo sales and marketing activity		21/10/20	121.87KB	Share
VHL	Cleansing Prospectus	PRICE SENSITIVE	20/10/20	3.55MB	Share
VHL	Placement investor presentation		20/10/20	1.26MB	Share
VHL	Proposed issue of Securities - RSH		20/10/20	29.98KB	Share
VHL	$12.5m Placement Completed	PRICE SENSITIVE	20/10/20	160.45KB	Share

VHL Voluntary Suspension
29/04/22	PRICE SENSITIVE	188KB	Share
VHL Trading Halt
27/04/22	PRICE SENSITIVE	187.99KB	Share
VHL Final Director's Interest Notice - TD
26/04/22		196.09KB	Share
VHL Director Resignation - TD
19/04/22		127.22KB	Share
VHL EAS Advisors LLC appointed to assist with US growth
29/03/22		174.07KB	Share
VHL Broker Briefing - full presentation
29/03/22		207.1KB	Share
VHL Tech/Biotech Webinar - presentation
24/03/22		1.07MB	Share
VHL CEO to present at Tech/Biotech Investor Webinar
23/03/22		228.35KB	Share
VHL RPM pilot program at Children's Hospital of Michigan
15/03/22	PRICE SENSITIVE	137.09KB	Share
VHL Notification regarding unquoted securities - RSH
25/02/22		27.76KB	Share
VHL Half Yearly Report and Accounts
21/02/22	PRICE SENSITIVE	1.53MB	Share
VHL Investor webinar and Q&A to be held Feb 23rd
21/02/22		120.38KB	Share
VHL Second RPM Agreement with Access TeleHealth
07/02/22	PRICE SENSITIVE	150.14KB	Share
VHL Respiri secures a second order from mTeleHealth
04/02/22	PRICE SENSITIVE	146.68KB	Share
VHL Proposed issue of securities - RSH
03/02/22		30.02KB	Share
VHL Quarterly Activities/Appendix 4C Cash Flow Report
28/01/22	PRICE SENSITIVE	312.71KB	Share
VHL Respiri enters Distribution/Marketing Agreement in USA
23/12/21	PRICE SENSITIVE	148.6KB	Share
VHL Respiri to present today at MST Financial Forum
25/11/21		140.23KB	Share
VHL Respiri to present at NWR Virtual Healthcare Day
22/11/21		120.82KB	Share
VHL Results of AGM
15/11/21		162.64KB	Share
VHL AGM - Chairman's Address and CEO presentation
15/11/21		2.03MB	Share
VHL Quarterly Activities/Appendix 4C Cash Flow Report
26/10/21	PRICE SENSITIVE	302.49KB	Share
VHL Notice of General Meeting
14/10/21		744.89KB	Share
VHL Annual Report - Corporate Governance Statement
27/08/21		166.24KB	Share
VHL Annual Report - App 4G
27/08/21		289.35KB	Share
VHL Preliminary Final Report
27/08/21	PRICE SENSITIVE	4.45MB	Share
VHL NWR Conference Presentation - amended
05/08/21		2.73MB	Share
VHL NWR Conference Presentation
03/08/21		3.08MB	Share
VHL Quarterly Activities/Appendix 4C Cash Flow Report
30/07/21	PRICE SENSITIVE	310.91KB	Share
VHL Respiri to present at NWR Virtual Investor Conference
29/07/21		120.47KB	Share
VHL Top 20 shareholders and Distribution Schedule
21/07/21		254.51KB	Share
VHL T/O Bid lapsed and Ceasing to be sub. shareholder for ADR
19/07/21		319.82KB	Share
VHL Defeating Conditions Notice
08/07/21		292.2KB	Share
VHL Clarification Announcement
05/07/21	PRICE SENSITIVE	389.56KB	Share
VHL Response to ASX Query
02/07/21	PRICE SENSITIVE	487.94KB	Share
VHL ADR: Despatch of Target's Statement
30/06/21		249.94KB	Share
VHL ADR: Target's Statement
28/06/21	PRICE SENSITIVE	9.29MB	Share
VHL Webinar presentation - Investor Update
23/06/21	PRICE SENSITIVE	3.05MB	Share
VHL Pharmacy Network to Commence Sales of wheezo
23/06/21	PRICE SENSITIVE	121.69KB	Share
VHL Change of Director's Interest Notice - MM
22/06/21		545.44KB	Share
VHL Investor webinar & Q&A
22/06/21		120.45KB	Share
VHL ADR: Letter to Shareholders re takeover offer
17/06/21	PRICE SENSITIVE	132.62KB	Share
VHL Notice of Dispatch
15/06/21		2.03MB	Share
VHL Trading Update
15/06/21	PRICE SENSITIVE	125.49KB	Share
VHL wheezo Registered and Approved for Sale in the UK Market
11/06/21		124.56KB	Share
VHL ADR: Adherium responds to Respiri announcement
07/06/21		126.28KB	Share
VHL RPM CPT Reimbursement & response to statements made by ADR
03/06/21		152.86KB	Share
VHL wheezo production update &Chief Commercial Offer appointment
31/05/21		374.65KB	Share
VHL Replacement Bidders Statement
27/05/21	PRICE SENSITIVE	2.47MB	Share
VHL 1st Supplementary Bidder's Statement(marked up replacement
27/05/21	PRICE SENSITIVE	2.7MB	Share
VHL Major Shareholder Update
27/05/21		944.58KB	Share
VHL Notice under section 633(4) Corps Act 2001
10/05/21		75.41KB	Share
VHL ADR: Adherium Directors' Statement re Takeover
10/05/21	PRICE SENSITIVE	138.41KB	Share
VHL Proposed issue of Securities - RSH
30/04/21		25.12KB	Share
VHL Notice of initial substantial holder for ADR
30/04/21		172.99KB	Share
VHL ADR: Adherium response to Respiri announcement
30/04/21	PRICE SENSITIVE	169.84KB	Share
VHL Bidder's Statement
29/04/21	PRICE SENSITIVE	2.02MB	Share
VHL Appendix 4C - quarterly
29/04/21	PRICE SENSITIVE	306.97KB	Share
VHL Respiri Partnership with TerryWhite Chemmart Group
28/04/21	PRICE SENSITIVE	120.61KB	Share
VHL Respiratory Physician led programme launching in Australia
29/03/21		121.76KB	Share
VHL Strategic Advisor Appointments and UK Update
25/03/21		139.27KB	Share
VHL Investor Presentation
23/03/21	PRICE SENSITIVE	1.89MB	Share
VHL US FDA Clearance received
23/03/21	PRICE SENSITIVE	160.2KB	Share
VHL Webinar and Q&A to be held tomorrow morning
22/03/21		115.08KB	Share
VHL Trading Halt
19/03/21	PRICE SENSITIVE	515.04KB	Share
VHL Investor Presentation - NWR conference
19/03/21		2.33MB	Share
VHL Appendix 2A - exercise of options
18/03/21		284.95KB	Share
VHL Proposed issue of Securities - RSH
18/03/21		24.22KB	Share
VHL Respiri to present at NWR Comm.s Virtual Investor Conference
15/03/21		115.14KB	Share
VHL Half Year Accounts
19/02/21	PRICE SENSITIVE	462.38KB	Share
VHL Pharmacy Catalyst Members In-Pharmacy Asthma Mgt Program
08/02/21		125.89KB	Share
VHL Change of Director's Interest Notice - TD
02/02/21		237.06KB	Share
VHL Change of Director's Interest Notice - MM
02/02/21		421.32KB	Share
VHL Change of Director's Interest Notice - NS
02/02/21		630.88KB	Share
VHL Appendix 4C - quarterly
27/01/21	PRICE SENSITIVE	330.59KB	Share
VHL Appendix 2A - exercise of options
18/01/21		285.58KB	Share
VHL SuperChem to Commence Sales of wheezo
14/01/21		103.52KB	Share
VHL Appendix 3G
29/12/20		334.48KB	Share
VHL Proposed issue of Securities - RSH
23/12/20		31.76KB	Share
VHL Results of Annual General Meeting
16/12/20		163.11KB	Share
VHL CEO's Update at AGM
16/12/20		1.46MB	Share
VHL Change of Director's Interest Notice - MM
16/12/20		414.94KB	Share
VHL Change of Director's Interest Notice - NS
16/12/20		637.22KB	Share
VHL New Partnership with Pharmacy 4 Less Banner Group
16/12/20		121.06KB	Share
VHL Company Update Post Commercial Launch
09/12/20	PRICE SENSITIVE	136.35KB	Share
VHL Michael Clarke Ambassador & Carlton AFLW co-sponsor
04/12/20		121.95KB	Share
VHL Appendix 2A
25/11/20		281.6KB	Share
VHL Notice of Annual General Meeting
12/11/20		1.94MB	Share
VHL Manufacturing update
04/11/20	PRICE SENSITIVE	141.03KB	Share
VHL wheezo Launch Update
30/10/20		124.52KB	Share
VHL Patent application filed - Next Generation wheezo algorithm
29/10/20		138.58KB	Share
VHL Appendix 2A
28/10/20		286.11KB	Share
VHL Amended - Change in substantial holding
23/10/20		1.46MB	Share
VHL Change in substantial holding
23/10/20		1.44MB	Share
VHL Appendix 4C - quarterly
22/10/20	PRICE SENSITIVE	332.42KB	Share
VHL Cipla launches wheezo sales and marketing activity
21/10/20		121.87KB	Share
VHL Cleansing Prospectus
20/10/20	PRICE SENSITIVE	3.55MB	Share
VHL Placement investor presentation
20/10/20		1.26MB	Share
VHL Proposed issue of Securities - RSH
20/10/20		29.98KB	Share
VHL $12.5m Placement Completed
20/10/20	PRICE SENSITIVE	160.45KB	Share

REFRESH

First 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 2.8¢		Change 0.001(3.70%)		Mkt cap ! $48.11M

Open	High	Low	Value	Volume
2.8¢	2.8¢	2.7¢	$85.93K	3.069M

Buyers (Bids)

No.	Vol.	Price($)
1	300000	2.7¢

Sellers (Offers)

Price($)	Vol.	No.
2.8¢	1231056	3

View Market Depth

No.	Vol.	Price($)
1	300000	0.027
5	1526001	0.026
8	329423	0.025
4	417000	0.024
1	152000	0.023

Price($)	Vol.	No.
0.028	1231056	3
0.029	610563	3
0.030	944470	5
0.031	628000	2
0.032	1000000	2

Last trade - 16.10pm 31/07/2025 (20 minute delay)


Last 2.8¢		Change 0.001 ( 3.70 %)
Open	High	Low	Volume
2.8¢	2.8¢	2.8¢	149093
Last updated 15.33pm 31/07/2025 ?

VHL (ASX) Chart

VITASORA HEALTH LIMITED - Announcements

Corporate Spotlight
Not Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

Resolution Minerals appoints industry experts to fast-track US growth strategy

Top Stories

VITASORA HEALTH LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

Resolution Minerals appoints industry experts to fast-track US growth strategy

Top Stories

Corporate Spotlight
Not Yet Available